Project Grant R01NS149758
- Federal Project Grant Award Summary Rutgers, The State University has received a $123,588 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through August 31, 2027. This award funds neurobehavioral research investigating the relationship between altered motor behavior and dopamine (DA) transients in the dorsolateral...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a $155,000 project grant effective July 8, 2025 through June 30, 2027 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The award supports the characterization of an aminoacyl-tRNA synthetase complex interacting multifunctional protein-2 (AIMP2) variant-linked mouse model of Parkinson's disease. The...
- Federal Grant Award Summary Award Details: The National Institute of Neurological Disorders and Stroke (NINDS) awarded Emory University a $540,901 Project Grant (CFDA 93.853 – Extramural Research Programs in the Neurosciences and Neurological Disorders) on April 15, 2026, with a completion date of March 31, 2031. The research will be conducted at Emory's Atlanta, Georgia location. Research Scope: This research project investigates changes in molecular mechanisms of dopamine signaling in advanced...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey received a $429,514 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded September 1, 2025, with completion anticipated by August 31, 2027. The research will be conducted at the institution's location in New Jersey and focuses on investigating myelin acquisition and...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $513,109 Project Grant to the University of Pennsylvania (awarded July 15, 2026; completion date April 30, 2031) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds the development of novel statistical methodologies designed to optimize individualized treatment regimens for Parkinson's Disease by simultaneously...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1.81 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 11, 2026, with a completion date of April 30, 2029. The grant supports research investigating LRRK2 (Leucine-Rich Repeat Kinase 2) signaling and its role in the progression of...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $422,125 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded August 15, 2025, with a completion date of July 31, 2027. The research focuses on characterizing the role of the DNAJC12 protein in dopamine biosynthesis and physiology through the...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $595,208 to The Regents of the University of California, San Francisco on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This five-year Project Grant, which extends through March 31, 2031, funds collaborative research investigating the cellular and circuit-level mechanisms underlying cognitive dysfunction and...
- Federal Project Grant Award Summary Rockefeller University received a $220,260 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2030. This five-year research initiative focuses on identifying molecular mechanisms underlying striatal dysfunction in Parkinson's disease by investigating the role of the...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) awarded $513,535 to The University of Texas Southwestern Medical Center beginning June 1, 2026, through May 31, 2030. This Project Grant supports structure-guided discovery of positive allosteric modulators (PAMs) for the D2 dopamine receptor (DRD2), a G protein-coupled receptor central...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded Rutgers The State University of New Jersey a Project Grant of $677,059 on July 17, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research, directed from Newark, New Jersey, and scheduled for completion by May 31, 2031, investigates the role of tonic dopamine release in Parkinsonian motor deficits. The project will define the molecular basis and network consequences of dopamine release defects that impair motor control by leveraging a Parkinson's disease-relevant genetic model. Specifically, the research examines synaptojanin1 (SYNJ1) deficiency and its effects on dopamine transporter recycling, dopamine storage in synaptic vesicles, and striatal circuit function using transgenic mouse models to elucidate mechanisms of early-stage motor dysfunction independent of widespread neuronal degeneration. The deliverables will include mechanistic findings on dopaminergic synaptic dysfunction, characterization of molecular feedback regulation pathways governing tonic dopamine release, and preclinical data on striatal circuit dysfunction resulting from SYNJ1 deficiency. These research outputs are expected to advance fundamental understanding of dopaminergic dysfunction in Parkinson's disease pathogenesis and potentially inform future therapeutic strategies targeting early symptomatic intervention before significant neurodegeneration occurs.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $677.1k | 7/17/26 |